SCHEMBL19620628

SCHEMBL19620628

Cc1cc(Cl)cc(C2OC(N)=C(OSCc3ccccc3)C2=O)c1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620689 0.92 KDM4E (0.38) KDM4EPOLBMAPT
SCHEMBL19620570 0.86 MAPT (0.39) KDM4EPOLBMAPT
SCHEMBL22902049 0.86 MAPT (0.39) KDM4EPOLBMAPT
SCHEMBL19620522 0.84 KDM4E (0.42) KDM4EPOLBMAPT
SCHEMBL19620675 0.84 MAPT (0.42) KDM4EPOLBMAPT
SCHEMBL19620603 0.83 POLB (0.50) KDM4EPOLBMAPT
SCHEMBL19620492 0.81 KDM4E (0.36) KDM4EPOLBMAPT
SCHEMBL19620577 0.81 EGFR (0.37) KDM4EPOLBMAPT
SCHEMBL19620548 0.81 MEN1 (0.40) KDM4EPOLBMAPT
SCHEMBL19620654 0.81 KDM4E (0.38) KDM4EPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed